Our Companies

• 2017 Founded by Romain Bessuges-Meusy, Delphine Dorseuil, and Laurent Thomas
• 2019 Launched the consent management platform
• 2023 Raised €3.5 million, joins the OVNI familiy
• 2023 Over 65,000 websites and 7,000 paying clients

• 2023 Founded by Mathieu Nohet and Marie Rouquette
• 2024 Raised a €3.3 M pre‑seed round and joined the OVNI Capital family
• 2024 Unveiled its “Docker for cells” biosynthetic isoprenoid platform

• 2021 Founded by Michaël Elalouf and Clément Larrue
• 2022 Launched first version of the platform to streamline B2B financing
• 2023 Secured initial seed funding to accelerate development
• 2024 Raised a $3.4M pre-seed round and joined the OVNI Capital family

• 2022: Founded by Aritz Zamacola, Vincent Hingot, and Olivier Couture as a spin-off from Sorbonne University.
• 2023: Raised €2.2M in Seed funding, joins the OVNI family
• 2023: Launched first clinical trials in collaboration with CHU Caen.
• 2023: Selected as one of the 5 finalists for the Nature Spinoff Prize.
• 2024: Enrolled first patients in a clinical trial using SYLVER ultrasound platform.

• 2024: Founded by Bastien Oggeri and Léa Dardenne.
• 2025: Raised €3M in pre-seed funding, joins the OVNI family

‍

• 2022: Founded by Florian Doumenc and Romain Doumenc in Paris.
• 2023: Winner of an EU project grant under the DIGITAL-ECCC-2022-CYBER-03 program.
• 2024: Collaborated with major industrial companies, including Thales and Orange, to develop industrial cybersecurity solutions.
• 2024: Joins the OVNI family

• 2023: Founded by Francesco Manegatti, Bruno Garbin, and Fabrice Raineri
• 2024: Raised €3.5M in Seed Funding, joins the OVNI fam'

• 2023 Founded by Gautier Bugeon
• 2024 Launched platform and land several clients
• 2024 Raised initial funding to scale operations and expand market reach, joined OVNI Capital

‍

• 2024 Founded by Sophia Mejjati Alami and Antoine Tessier
• 2025 Raised initial funding, joined OVNI Capital

‍